Monique Nilsson Selected Research

Aspirin (Acetylsalicylic Acid)

11/2020

Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monique Nilsson Research Topics

Disease

9	Neoplasms (Cancer) 07/2022 - 07/2006
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 07/2006
2	Adenocarcinoma of Lung 07/2022 - 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 11/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Carcinogenesis 01/2021
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Malignant Mesothelioma 01/2018
1	Neuroblastoma 02/2008

Drug/Important Bio-Agent (IBA)

5	Tyrosine Kinase InhibitorsIBA 07/2022 - 02/2008
3	ErbB Receptors (EGF Receptor)IBA 07/2016 - 07/2006
2	Bevacizumab (Avastin)FDA Link 07/2022 - 02/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 02/2008
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2014
2	vandetanib (ZD6474)IBA 02/2008 - 07/2006
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2008 - 07/2006
1	N 30IBA 07/2022
1	NADP (NADPH)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	NucleosidesIBA 01/2022
1	NucleotidesIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 11/2021
1	CarcinogensIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020
1	osimertinibIBA 11/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2018
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	HhAntag691IBA 11/2017
1	Polo-Like Kinase 1IBA 07/2016
1	AntigensIBA 05/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2008
1	Monoclonal AntibodiesIBA 02/2008
1	Mitogen-Activated Protein KinasesIBA 02/2008
1	Proto-Oncogene Proteins c-retIBA 02/2008
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2008
1	Cetuximab (Erbitux)FDA Link 07/2006
1	Gefitinib (Iressa)FDA Link 07/2006

Therapy/Procedure

2	Therapeutics 11/2021 - 01/2021
1	Immunotherapy 07/2022
1	Drug Therapy (Chemotherapy) 07/2022
1	Aftercare (After-Treatment) 02/2008